3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
20
INDUSTRY
5
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
3
Gliosarcoma
2
Glioblastoma
2
Central Nervous System Neoplasms
2
Breast Neoplasms, Male
2
Waldenstrom Macroglobulinemia
1
Somatostatinoma
1
Sarcoma
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Mesothelioma, Malignant
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Insulinoma
1
Immunoblastic Lymphadenopathy
1
Glucagonoma
1
Interventions
Gene Expression Profiling
7
Polymerase Chain Reaction
5
Filgrastim
5
Doxorubicin
5
Radiotherapy
3
Gemcitabine
3
Cyclophosphamide
3
Amplified Fragment Length Polymorphism Analysis
3
Vincristine
2
Reverse Transcriptase Polymerase Chain Reaction
2
Radiosurgery
2
Microarray Analysis
2
Interferon-alpha
2
Immunohistochemistry
2
Ifosfamide
2
Granulocyte Colony-Stimulating Factor
2
Etoposide
2
Dactinomycin
2
DNA Methylation
2
Cytogenetic Analysis
2
Chemotherapy, Adjuvant
2
Carboplatin
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
siltuximab
1
peginterferon alfa-2b
1
pegfilgrastim
1
aldesleukin
1
Traumeel S
1
Sunitinib
1
Spectrum Analysis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Kidney Neoplasms
×
Everolimus
×
Clear all
NCT01120249
2025-09-16
S0931
SWOG Cancer Research Network
Phase 3
Completed
1,545 enrolled
15 charts